Pitt Pharmacy professor Sandra Kane-Gill was recently awarded two grants from the National Institute of Diabetes and Digestive and Kidney Diseases.
The first grant is for a project entitled, “Multi-hospital Implementation of an Electronic Decision Support System for Drug-associated AKI,” in which she is a co-principal investigator along with Pitt Pharmacy faculty members Colleen Culley, Pamela Smithburger and Alexis Gaggini.
The project will assess the effectiveness of a clinical surveillance alert system augmented with real-time EMR predictive analytics to support a pharmacist-led intervention to reduce the progression and complications of drug-associated acute kidney injury. This work advances Kane-Gill’s research program theme of medication safety and nephrotoxin stewardship.
The second grant focuses on processes of care after acute kidney injury hospitalization, which have been found to be suboptimal — with lack of continuity of care, delayed follow-up, and suboptimal medication management exacerbating the risks of adverse outcomes.